Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis

PaperCitations, authors & open-access status

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 26 citations, 2019 year and gold oa status.

26
Citations
2019
Year
gold
OA Status

Related on ScholarIQ

Holly Mansell
Author
BMC Health Services Research
Journal
Biosimilars and Bioanalytical Methods
Topic
Biosimilars and Bioanalytical Methods
Topic
Neutropenia and Cancer Infections
Topic
Clostridium difficile and Clostridium perfringens research
Topic
470M+ articles · free account